Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of phosphodiesterase inhibitors in the treatment of prostatic diseases

Use of phosphodiesterase inhibitors in the treatment of prostatic diseases

US Patent 8106061 · Granted Jan 31, 2012

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Polypeptides for the treatment of diseases2021
Peptides with antagonistic activities against natural CXCR42019
Protransduzin B, a gene transfer enhancer2018
Process for preparing human relaxin-22016
Use of natriuretic peptide for treating heart failure2016
CXC chemokine receptor 4 (CXCR4) antagonistic polypeptide2015
Use of natriuretic peptide for treating heart failure2015
Use of phosphordiesterase inhibitors in the treatment of prostatic diseases2014
Use of phosphordiesterase inhibitors in the treatment of prostatic diseases2014
Use of phosphordiesterase inhibitors in the treatment of prostatic diseases2014
Use of phosphordiesterase inhibitors in the treatment of prostatic diseases2014
Use of natriuretic peptide for treating heart failure2014